Resistance phenotype and genetic features of a heterogeneous vancomycin intermediate–resistant Staphylococcus aureus strain from an immunocompromised patient-Reference-Cited by-同舟云学术

Resistance phenotype and genetic features of a heterogeneous vancomycin intermediate–resistant Staphylococcus aureus strain from an immunocompromised patient

Published:2023-12-07 Issue: Volume: Page:
ISSN:1517-8382
Container-title:Brazilian Journal of Microbiology
language:en
Short-container-title:Braz J Microbiol

Author:

Cheng Xin,Wang Yaru,Ma Jingxin,Ma Liyan,Sun Wei,Su Jianrong^ORCID

Funder

National Key Research and Development Program of China

National key inspection specialty construction projects

Publisher

Springer Science and Business Media LLC

Subject

Microbiology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s42770-023-01192-y.pdf

Reference43 articles.

1. Hiramatsu K, Aritaka N, Hanaki H, Kawasaki S, Hosoda Y, Hori S et al (1997) Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin. Lancet 350:1670–1673. https://doi.org/10.1016/S0140-6736(97)07324-8

2. Hiramatsu K, Hanaki H, Ino T, Yabuta K, Oguri T, Tenover FC (1997) Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility. J Antimicrob Chemother 40:135–136. https://doi.org/10.1093/jac/40.1.135

3. Maor Y, Hagin M, Belausov N, Keller N, Ben-David D, Rahav G (2009) Clinical features of heteroresistant vancomycin-intermediate Staphylococcus aureus bacteremia versus those of methicillin-resistant S. aureus bacteremia. J Infect Dis 199:619–624. https://doi.org/10.1086/596629

4. Wootton M, Howe RA, Hillman R, Walsh TR, Bennett PM, MacGowan AP (2001) A modified population analysis profile (PAP) method to detect hetero-resistance to vancomycin in Staphylococcus aureus in a UK hospital. J Antimicrob Chemother 47:399–403. https://doi.org/10.1086/596629

5. Matsuo M, Cui L, Kim J, Hiramatsu K (2013) Comprehensive identification of mutations responsible for heterogeneous vancomycin-intermediate Staphylococcus aureus (hVISA)-to-VISA conversion in laboratory-generated VISA strains derived from hVISA clinical strain Mu3. Antimicrob Agents Chemother 57:5843e53. https://doi.org/10.1128/AAC.00425-13

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Diagnostic value of BHI-V4 for heterogeneous and vancomycin-intermediate Staphylococcus aureus isolates: a systematic review and meta-analysis;BMC Infectious Diseases;2024-05-14